Synthesis and Evaluation of AS1411-Lenalidomide-Targeted Degradation Chimera in Antitumor Therapy.

Saved in:
Bibliographic Details
Title: Synthesis and Evaluation of AS1411-Lenalidomide-Targeted Degradation Chimera in Antitumor Therapy.
Authors: Ma, Xueling1,2 (AUTHOR), Liu, Shuangshuang2,3 (AUTHOR), Dong, Xiao2,3,4 (AUTHOR), Li, Xiuhua2,4,5 (AUTHOR), Wang, Feiyan2,3,5 (AUTHOR), Zhang, Jiawei1,2 (AUTHOR), Xu, Zhenfang2 (AUTHOR), Shi, Weiguo2,3 (AUTHOR), Zheng, Aiping2,4 (AUTHOR), Zhang, Aiping4,5 (AUTHOR), Feng, Xuesong3 (AUTHOR), Xu, Liang2 (AUTHOR)
Source: Pharmaceuticals (14248247). Dec2025, Vol. 18 Issue 12, p1867. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 190524690
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Synthesis and Evaluation of AS1411-Lenalidomide-Targeted Degradation Chimera in Antitumor Therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Ma%2C+Xueling%22">Ma, Xueling</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Shuangshuang%22">Liu, Shuangshuang</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dong%2C+Xiao%22">Dong, Xiao</searchLink><relatesTo>2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Xiuhua%22">Li, Xiuhua</searchLink><relatesTo>2,4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Feiyan%22">Wang, Feiyan</searchLink><relatesTo>2,3,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Jiawei%22">Zhang, Jiawei</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Zhenfang%22">Xu, Zhenfang</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shi%2C+Weiguo%22">Shi, Weiguo</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zheng%2C+Aiping%22">Zheng, Aiping</searchLink><relatesTo>2,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Aiping%22">Zhang, Aiping</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Feng%2C+Xuesong%22">Feng, Xuesong</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Liang%22">Xu, Liang</searchLink><relatesTo>2</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Pharmaceuticals+%2814248247%29%22">Pharmaceuticals (14248247)</searchLink>. Dec2025, Vol. 18 Issue 12, p1867. 15p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=190524690
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/ph18121867
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 15
        StartPage: 1867
    Titles:
      – TitleFull: Synthesis and Evaluation of AS1411-Lenalidomide-Targeted Degradation Chimera in Antitumor Therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ma, Xueling
      – PersonEntity:
          Name:
            NameFull: Liu, Shuangshuang
      – PersonEntity:
          Name:
            NameFull: Dong, Xiao
      – PersonEntity:
          Name:
            NameFull: Li, Xiuhua
      – PersonEntity:
          Name:
            NameFull: Wang, Feiyan
      – PersonEntity:
          Name:
            NameFull: Zhang, Jiawei
      – PersonEntity:
          Name:
            NameFull: Xu, Zhenfang
      – PersonEntity:
          Name:
            NameFull: Shi, Weiguo
      – PersonEntity:
          Name:
            NameFull: Zheng, Aiping
      – PersonEntity:
          Name:
            NameFull: Zhang, Aiping
      – PersonEntity:
          Name:
            NameFull: Feng, Xuesong
      – PersonEntity:
          Name:
            NameFull: Xu, Liang
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 14248247
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Pharmaceuticals (14248247)
              Type: main
ResultId 1